Shulga: Advocating healthy weight loss concepts, spreading healthy weight loss methods

2024-09-29

Classification:Dynamics

Shulga Orlistat Capsules is an OTC weight loss drug of Lunan Pharmaceutical Group, which is certified by FDA, EMA and CFDA, with guaranteed quality. Shulga always advocates healthy weight loss, and is committed to spreading the correct, healthy weight loss concept, to help more people easily slimming, to achieve the purpose of “oil control, fat control, weight loss, weight loss”.

When it comes to weight loss, there are only two key words in the average person's weight loss lexicon: diet and exercise. Dieting can certainly reduce calorie intake, but excessive dieting can lead to malnutrition, lower basal metabolic rate, easy to rebound. For many people who are busy with work and study, it is also difficult to find enough time to exercise, and it is precisely because of the poor performance in both “eating” and “moving” that has led to the growing number of obese people.


The emergence of Shulga provides a new way out for the weight loss crowd, Shulga mainly through the inhibition of gastric lipase in the stomach and pancreatic lipase activity in the lumen of the small intestine, so that 30% of dietary fat can not be absorbed by the human body, to reduce the calorie intake from the source. At the same time, due to insufficient exogenous fat intake, the body will consume its own fat to provide energy, so that consumption > intake, so as to achieve the purpose of weight loss.


As soon as Shulga was launched, it was well received by consumers. “One capsule with meal, easy to lose weight” such a way of taking has been accepted by more and more people, to achieve the purpose of ‘oil control, fat control, weight loss, weight loss’.




I. Mechanism of action


Shuljia Orlistat Capsules is a long-acting and potent specific gastrointestinal lipase inhibitor, which exerts its therapeutic effect by forming covalent bonds with the active serine sites of gastric lipase in the stomach and pancreatic lipase in the lumen of the small intestine, inactivating the enzymes. Inactivated enzymes are unable to hydrolyze dietary fats, primarily triglycerides, into absorbable free fatty acids and monoacylglycerols. Undigested triglycerides cannot be absorbed by the body, thereby reducing caloric intake and controlling body weight. The drug does not exert its effects through systemic absorption.


As far as its effectiveness is concerned, as a gastrointestinal lipase inhibitor, it exerts its fat-reducing and weight-loss effects through both direct and indirect actions: on the one hand, it “blocks the source of goods” by inhibiting the activity of lipase and directly blocking the absorption of fats from food; on the other hand, it “depletes the stock” by reducing exogenous sources of fat. On the one hand, it is “blocking the source”, which directly blocks the absorption of fat from food by inhibiting lipase activity; on the other hand, it is “consuming the stock”, which indirectly increases the consumption of accumulated fat in the body by reducing the intake of external sources.


 

Applicable people


Obesity with three high: obesity and obesity with three high chronic diseases caused by obesity crowd.


Poor body image: people who want to get rid of the nightmare of obesity by being made “fat” by others.


Youth obesity: over-nutrition, weight problems affecting the healthy growth of the crowd.


Postpartum slimming (non-lactating): postpartum bloated body, want to find the original self-confidence of the crowd.


Beauty-loving women (white-collar workers and professionals): people who have strict requirements on body shape and want to maintain their body shape for a long time.


Business socializing: general belly, beer belly, business socializing crowd.



Third, the use of the effect


Orlistat has been marketed in more than 100 countries around the world, after more than 70 million users around the world for sixteen years of verification, is approved by the U.S. FDA, the European Union EMA and the Chinese Food and Drug Administration to market the only OTC weight loss drug has now become the first choice for healthy weight loss.


Orlistat begins to detoxify 24-48 hours after taking it and may have a beneficial effect in reducing adverse cardiovascular events. This result has been fully scientifically verified by more than 200 clinical studies conducted by 7 domestic authoritative scientific research institutions.


The World Health Organization stipulates that healthy weight loss should follow the principle of uniform weight loss of 0.5~1 kg per week. The faster you lose weight, the more powerful the rebound.


Fourth, biological fermentation natural health


Unlike the chemically synthesized orlistat products currently on the market, Shulga adopts a natural bio-fermentation process, utilizing high-quality soybeans, glucose and other natural raw materials as raw materials for bio-fermentation, after dozens of days of high-temperature fermentation, the highest purity of raw materials up to 99.99%.


From the biological fermentation and chemical synthesis level, the chemical synthesis method is characterized by the existence of high temperature, high pressure, strong acid, strong alkali and other extreme chemical processes, low production safety, environmental pollution, while microbial fermentation method for the production of organic acids, its production conditions are relatively mild, generally does not exist in high temperature, high pressure, strong acid and alkali and other extreme reaction conditions, the three wastes are relatively less emissions. Shulga orlistat capsules, invested hundreds of millions of dollars, after more than ten years of potential research and development, innovative use of complex biological fermentation technology, in order to better combine technology and health, really let the power of science and technology, service to people's slimming health.



V. Award-winning


As the leading orlistat brand in China, Lunan Pharmaceutical Orlistat Program was established in 2004;


In 2007, Lunan Pharmaceutical Orlistat project was included in the science and technology development plan of Linyi City;


In 2008, Lunan Pharmaceutical Orlistat project applied for 3 patents, 3 were approved, and Lunan Pharmaceutical “Orlistat Fermentation Clean Production Engineering Technology Research” was listed as a national support program topic (2008BAI67B04);


In 2013, Orlistat of Lunan Pharmaceutical was appraised by Shandong Provincial Science and Technology Department to be internationally advanced;


In May 2014, Shuljia orlistat capsule was approved by CFDA;


In November 2015, it was awarded the title of “The Eighth Healthy China (2015) Consumer Trusted Health Medicine Excellent Brand”;


In December 2015, Shulka's invention patent (ZL201110370659.2) was honored with China Patent Gold Award at the 17th China Patent Award Conference;


In November 2016, it won the second place in the comprehensive statistical ranking of China's non-prescription drug products in 2016 (chemical drugs Lifestyle category);


In November 2017, won the title of “2017 China Chemical Pharmaceutical Industry OTC Excellent Product Brand”;


In December 2017, won the first place in the 2017 China OTC product comprehensive statistical ranking (chemical medicine Lifestyle category);


In January 2018, it was awarded the 2017 Healthy China General Rating List Brand of the Year;




In August 2018, Jiajia (mascot of Shulgia Orlistat Capsules) won the Gold Award for IP Commercial Value at the Advertiser International Awards.


In September 2018, Shujia won the “Health Golden Deer Award 2018 Best Growth Award”.


In October 2018, Shuerjia's “Weight Loss Battle” was honored with the Gold Medal Case of the Year at the 2018 Advertisers' Ceremony! 


 In November 2018, China's OTC Comprehensive Statistical Ranking (Chemical) Lifestyle Category No. 1




Until now, Shuljia Orlistat Capsules have declared 23 Chinese patents and been authorized 18.